Erratum to 'Pulmonary metastases in a bilateral carotid body paraganglioma': [Interact CardioVasc Thorac Surg 3(2004)578-580]

Franco, Carlos García; Heili, Sarah; Hiscock, Luis Jiménez; Gaviria, J. Zapatero

doi:10.1510/icvts.2011.086835

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among these articles, 20 (158 patients) included 5 or more patients (Table 1) 18–39 and were considered for the proportion MA. The remaining 112 studies (179 patients), represented by case reports or case series with <5 patients, are reported in Table S1 3,40–152 …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature

Piazza,

Lancini,

Tomasoni

et al. 2024

Head & Neck

View full text Add to dashboard Cite

Malignant carotid body tumors (MCBT) are rare and diagnosed after detection of nodal or distant metastases. This systematic review (SR) focuses on MCBT initially approached by surgery. Preferred Reporting Items for SR and Meta‐Analysis (MA) guided the articles search from 2000 to 2023 on PubMed, Scopus, and Web of Science. Among 3548 papers, 132 (337 patients) were considered for SR; of these, 20 (158 patients) for MA. Malignancy rate was 7.3%, succinate dehydrogenase (SDH) mutation 17%, age at diagnosis between 4th and 6th decades, with a higher prevalence of females. MCBTs were mostly Shamblin III, with nodal and distant metastasis in 79.7% and 44.7%, respectively. Malignancy should be suspected if CBT >4 cm, Shamblin III, painful or otherwise symptomatic, at the extremes of age, bilateral, with multifocal disease, and SDHx mutations. Levels II–III clearance should be performed to exclude nodal metastases and adjuvant treatments considered on a case‐by‐case basis.

show abstract

Section: Resultsmentioning

confidence: 99%

“…For proportion meta‐analysis (MA), only case series with at least five consecutive cases were considered (Table 1). 18–39 All the other case series describing less than five patients (including case reports) were considered only for the SR and detailed in Table S1 3,40–152 …”

Section: Methodsmentioning

confidence: 99%

Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature

Piazza,

Lancini,

Tomasoni

et al. 2024

Head & Neck

View full text Add to dashboard Cite

show abstract

Pulmonary Metastases from Carotid Body Paraganglioma

Ogura

Hishii

Takahashi

et al. 2012

Juntendo Medical Journal

View full text Add to dashboard Cite

Case presentation A 43-year-old female visited a local hospital in July 2003 because of a 2-months history of a painless mass in her right cervical area. She had no family history of paraganglioma. Magnetic resonance imaging of her head and neck revealed an enhanced mass near the right carotid body(Fig-ure─1). She underwent surgery for the removal of the mass, which was histologically diagnosed as a carotid body paraganglioma. As a postoperative complication, she developed a cerebral infarction in the right internal carotid artery area and suffered from left-sided hemiplegia. Two years later, small pulmonary nodules in both lungs were detected by a routine chest X-ray examination. Thereafter, she was transferred to our hospital for further evaluation and treatment. Physical examination revealed no abnormalities except for dysphagia, left facial palsy, and left limb weakness due to the cerebral infarction. Laborato

show abstract

Erratum to 'Pulmonary metastases in a bilateral carotid body paraganglioma': [Interact CardioVasc Thorac Surg 3(2004)578-580]

Cited by 2 publications

References 0 publications

Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature

Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature

Pulmonary Metastases from Carotid Body Paraganglioma

Contact Info

Product

Resources

About